Is a 12-week trial sufficient to evaluate clinical responses to etanercept or MTX treatment in early RA?

Rheumatology (Oxford). 2010 Jun;49(6):1201-3. doi: 10.1093/rheumatology/keq036. Epub 2010 Feb 24.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Arthritis, Rheumatoid / drug therapy*
  • Clinical Trials as Topic
  • Disease Progression
  • Humans
  • Methotrexate / therapeutic use*
  • Middle Aged
  • Time Factors
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Young Adult

Substances

  • Tumor Necrosis Factor-alpha
  • Methotrexate